Patent Assignment
Reel/Frame 044011/0402
Assignment of Assignor's Interest
Recorded: 2017-11-01
Pages: 8
Assignors
BEBBINGTON, CHRISTOPHER R.
Executed: 2017-05-23
YARRANTON, GEOFFREY T.
Executed: 2017-05-24
PALATH, VARGHESE
Executed: 2017-05-30
Assignee
KALOBIOS PHARMACEUTICALS INC.
1000 MARINA BOULEVARD, SUITE 250, BRISBANE, CALIFORNIA, 94005-1878
Covered Property
(1)
Treatment of Leukemias and Chronic Myeloproliferative Diseases with Antibodies to EphA3
Application:
15/265,625 →
Publication:
US 2017/0226227
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest
Dec 22, 2016
From: KALOBIOS PHARAMECUTICALS, INC.
To: BLACK HORSE CAPITAL MASTER FUND LTD.
Reel/Frame 041181/0605 →
Change of Name
Nov 2, 2017
From: KALABIOS PHARMACEUTICALS, INC.
To: HUMANIGEN, INC.
Reel/Frame 044680/0739 →
Release of Security Interest
Mar 30, 2018
From: BLACK HORSE CAPITAL MASTER FUND LTD.
To: KALOBIOS PHARAMECUTICALS, INC.
Reel/Frame 045855/0533 →